Cargando…

The Biopontis Alliance Rare Disease Foundation (BARDF) – an innovative model for early stage rare disease therapy financing and development

Detalles Bibliográficos
Autores principales: Tambuyzer, Erik T, Handelin, Barbara L, Basile, Richard A, Haffner, Marlene E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4249604/
http://dx.doi.org/10.1186/1750-1172-9-S1-O18
_version_ 1782346866278531072
author Tambuyzer, Erik T
Handelin, Barbara L
Basile, Richard A
Haffner, Marlene E
author_facet Tambuyzer, Erik T
Handelin, Barbara L
Basile, Richard A
Haffner, Marlene E
author_sort Tambuyzer, Erik T
collection PubMed
description
format Online
Article
Text
id pubmed-4249604
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42496042014-12-02 The Biopontis Alliance Rare Disease Foundation (BARDF) – an innovative model for early stage rare disease therapy financing and development Tambuyzer, Erik T Handelin, Barbara L Basile, Richard A Haffner, Marlene E Orphanet J Rare Dis Oral Presentation BioMed Central 2014-11-11 /pmc/articles/PMC4249604/ http://dx.doi.org/10.1186/1750-1172-9-S1-O18 Text en Copyright © 2014 Tambuyzer et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Oral Presentation
Tambuyzer, Erik T
Handelin, Barbara L
Basile, Richard A
Haffner, Marlene E
The Biopontis Alliance Rare Disease Foundation (BARDF) – an innovative model for early stage rare disease therapy financing and development
title The Biopontis Alliance Rare Disease Foundation (BARDF) – an innovative model for early stage rare disease therapy financing and development
title_full The Biopontis Alliance Rare Disease Foundation (BARDF) – an innovative model for early stage rare disease therapy financing and development
title_fullStr The Biopontis Alliance Rare Disease Foundation (BARDF) – an innovative model for early stage rare disease therapy financing and development
title_full_unstemmed The Biopontis Alliance Rare Disease Foundation (BARDF) – an innovative model for early stage rare disease therapy financing and development
title_short The Biopontis Alliance Rare Disease Foundation (BARDF) – an innovative model for early stage rare disease therapy financing and development
title_sort biopontis alliance rare disease foundation (bardf) – an innovative model for early stage rare disease therapy financing and development
topic Oral Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4249604/
http://dx.doi.org/10.1186/1750-1172-9-S1-O18
work_keys_str_mv AT tambuyzererikt thebiopontisalliancerarediseasefoundationbardfaninnovativemodelforearlystagerarediseasetherapyfinancinganddevelopment
AT handelinbarbaral thebiopontisalliancerarediseasefoundationbardfaninnovativemodelforearlystagerarediseasetherapyfinancinganddevelopment
AT basilericharda thebiopontisalliancerarediseasefoundationbardfaninnovativemodelforearlystagerarediseasetherapyfinancinganddevelopment
AT haffnermarlenee thebiopontisalliancerarediseasefoundationbardfaninnovativemodelforearlystagerarediseasetherapyfinancinganddevelopment
AT tambuyzererikt biopontisalliancerarediseasefoundationbardfaninnovativemodelforearlystagerarediseasetherapyfinancinganddevelopment
AT handelinbarbaral biopontisalliancerarediseasefoundationbardfaninnovativemodelforearlystagerarediseasetherapyfinancinganddevelopment
AT basilericharda biopontisalliancerarediseasefoundationbardfaninnovativemodelforearlystagerarediseasetherapyfinancinganddevelopment
AT haffnermarlenee biopontisalliancerarediseasefoundationbardfaninnovativemodelforearlystagerarediseasetherapyfinancinganddevelopment